GAP Score and CA-153 Associated with One-Year Mortality in Anti-MDA-5 Antibody-Positive Patients: A Real-World Experience.

Chih-Wei TsengKao-Lun WangChih-Cheng LaiCheng-Yi HuangTsu-Yi HsiehChia-Wei HsiehKuo-Lung LaiWei-Ting HungChing-Tsai LinKuo-Tung TangYi Ming ChenWen-Nan HuangYi-Hsing Chen

Published in: Journal of clinical medicine (2021)

Our study results suggest that GAP scores and CA-153 could be prognostic factors for 1-year mortality in anti-MDA-5 antibody-positive patients. A prompt pulmonary function test and CA-153 are essential for these patients to guide further management.

Keyphrases

prognostic factors
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
risk factors
coronary artery disease
patient reported outcomes